Low Raymond Anthony
Insider CIK 1391388 · AXTI Chief Financial Officer · SCLN VP, Finance & Controller, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-10-13 | 2017-10-16 | 2,500 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 3,988 | $2.35 | $9.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 15,923 | $2.06 | $32.8K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 19,077 | $2.06 | $39.3K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 50,000 | $6.43 | $321.5K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 24,426 | $1.53 | $37.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 10,574 | $1.53 | $16.2K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-10-13 | 2017-10-16 | 5,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 31,012 | $2.35 | $72.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-10-13 | 2017-10-16 | 3,750 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-10-13 | 2017-10-16 | 11,250 | — | $0 | 37,748 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer | 2017-10-13 | 2017-10-16 | 37,748 | $11.18 | $422.0K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-08-15 | 2017-08-16 | 10,000 | — | $0 | 11,250 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-08-15 | 2017-08-16 | 10,000 | — | $0 | 25,536 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-06-12 | 2017-06-14 | 1,250 | — | $0 | 21,250 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-06-12 | 2017-06-14 | 1,250 | — | $0 | 15,536 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2017-03-15 | 2017-03-17 | 1,250 | — | $0 | 22,500 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2017-03-15 | 2017-03-17 | 1,250 | — | $0 | 13,513 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-03-08 | 2017-03-09 | 10,574 | — | $0 | 10,574 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-03-08 | 2017-03-09 | 24,426 | — | $0 | 24,426 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-03-08 | 2017-03-09 | 5,000 | — | $0 | 23,750 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-08-12 | 2016-08-16 | 1,250 | — | $0 | 18,750 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-08-12 | 2016-08-16 | 10,000 | — | $0 | 20,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-08-12 | 2016-08-16 | 1,250 | — | $0 | 10,908 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-03-15 | 2016-03-17 | 15,923 | — | $0 | 15,923 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-03-15 | 2016-03-17 | 19,077 | — | $0 | 19,077 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-03-15 | 2016-03-17 | 5,000 | — | $0 | 10,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-03-16 | 2015-03-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-03-16 | 2015-03-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-10-15 | 2013-10-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AXTI AXT INC | A Award deriv | 2012-11-05 | 2012-11-19 | 24,000 | $2.91 | $69.8K | 228,750 | SEC↗ |
| AXTI AXT INC | A Award | 2012-11-05 | 2012-11-19 | 8,000 | — | $0 | 56,000 | SEC↗ |